The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $277.65

Today's change+4.71 +1.73%
Updated May 25 10:38 AM EDT. Delayed by at least 15 minutes.
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $277.65

Today's change+4.71 +1.73%
Updated May 25 10:38 AM EDT. Delayed by at least 15 minutes.

Biogen Inc up sharply

Biogen Inc is up sharply today, rallying (U.S.)$4.71 or 1.73% to (U.S.)$277.65. Over the last five days, shares have gained 5.06%, but are down 9.37% for the last year to date. Shares have underperformed the S&P 500 by 28.76% during the last year.

Key company metrics

  • Open(U.S.) $273.73
  • Previous close(U.S.) $272.94
  • High(U.S.) $279.46
  • Low(U.S.) $273.51
  • Bid / Ask(U.S.) $277.66 / (U.S.) $277.80
  • YTD % change-9.37%
  • Volume460,786
  • Average volume (10-day)1,180,744
  • Average volume (1-month)1,462,194
  • Average volume (3-month)1,800,920
  • 52-week range(U.S.) $242.07 to (U.S.) $420.99
  • Beta0.84
  • Trailing P/E17.06×
  • P/E 1 year forward14.49×
  • Forward PEG1.51×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $16.28
Updated May 25 10:38 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.69%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue2,7272,8392,7782,592
Total other revenue--------
Total revenue2,7272,8392,7782,592
Gross profit2,4142,5082,4682,306
Total cost of revenue313332310286
Total operating expense1,3481,6711,4061,359
Selling / general / administrative497583478492
Research & development437542520491
Depreciation / amortization89979892
Interest expense (income), net operating--------
Unusual expense (income)121180-2
Other operating expenses, total--------
Operating income1,3781,1681,3721,233
Interest income (expense), net non-operating-63-67-16-6
Gain (loss) on sale of assets--------
Other--------
Income before tax1,3261,0861,3561,222
Income after tax9698291,026930
Income tax, total356257330293
Net income971832966927
Total adjustments to net income--------
Net income before extra. items971832966927
Minority interest23-542
Equity in affiliates00-7-5
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items971832966927
Inc. avail. to common incl. extra. items971832966927
Diluted net income971832966927
Dilution adjustment--------
Diluted weighted average shares219221233236
Diluted EPS excluding extraordinary itemsvalue per share4.433.774.153.93
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share4.474.174.153.93